MX344783B - Metodo y agente para detectar farmacos en bebidas. - Google Patents
Metodo y agente para detectar farmacos en bebidas.Info
- Publication number
- MX344783B MX344783B MX2012015103A MX2012015103A MX344783B MX 344783 B MX344783 B MX 344783B MX 2012015103 A MX2012015103 A MX 2012015103A MX 2012015103 A MX2012015103 A MX 2012015103A MX 344783 B MX344783 B MX 344783B
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical form
- fcf
- colorant
- beverage
- beverages
- Prior art date
Links
- 235000013361 beverage Nutrition 0.000 title abstract 3
- 239000003795 chemical substances by application Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 abstract 2
- 239000003086 colorant Substances 0.000 abstract 2
- 235000012732 erythrosine Nutrition 0.000 abstract 2
- 239000004174 erythrosine Substances 0.000 abstract 2
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 abstract 2
- 235000012738 indigotine Nutrition 0.000 abstract 2
- 239000004179 indigotine Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 239000004214 Fast Green FCF Substances 0.000 abstract 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 abstract 1
- OIQPTROHQCGFEF-QIKYXUGXSA-L Sunset Yellow FCF Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-QIKYXUGXSA-L 0.000 abstract 1
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000012745 brilliant blue FCF Nutrition 0.000 abstract 1
- 239000004161 brilliant blue FCF Substances 0.000 abstract 1
- 229940055580 brilliant blue fcf Drugs 0.000 abstract 1
- 238000004040 coloring Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- RAGZEDHHTPQLAI-UHFFFAOYSA-L disodium;2',4',5',7'-tetraiodo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C([O-])C(I)=C1OC1=C(I)C([O-])=C(I)C=C21 RAGZEDHHTPQLAI-UHFFFAOYSA-L 0.000 abstract 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 abstract 1
- 229940011411 erythrosine Drugs 0.000 abstract 1
- 235000019240 fast green FCF Nutrition 0.000 abstract 1
- 229960003988 indigo carmine Drugs 0.000 abstract 1
- GUEIZVNYDFNHJU-UHFFFAOYSA-N quinizarin Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(O)=CC=C2O GUEIZVNYDFNHJU-UHFFFAOYSA-N 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 235000012751 sunset yellow FCF Nutrition 0.000 abstract 1
- 239000004173 sunset yellow FCF Substances 0.000 abstract 1
- 235000012756 tartrazine Nutrition 0.000 abstract 1
- 239000004149 tartrazine Substances 0.000 abstract 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 abstract 1
- 229960000943 tartrazine Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
- G01D7/00—Indicating measured values
- G01D7/005—Indication of measured value by colour change
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1055490A FR2962550B1 (fr) | 2010-07-06 | 2010-07-06 | Methode pour lutter contre la soumission chimique, utilisation d'agent colorant pour lutter contre la soumission chimique et composition pharmaceutique permettant la mise en oeuvre de la methode |
| PCT/FR2011/051600 WO2012010765A1 (fr) | 2010-07-06 | 2011-07-05 | Methode et agent pour la detection de drogues dans les boisson |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2012015103A MX2012015103A (es) | 2013-05-28 |
| MX344783B true MX344783B (es) | 2017-01-06 |
Family
ID=43587415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012015103A MX344783B (es) | 2010-07-06 | 2011-07-05 | Metodo y agente para detectar farmacos en bebidas. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20130098286A1 (enExample) |
| EP (1) | EP2591350B1 (enExample) |
| JP (1) | JP5916723B2 (enExample) |
| KR (2) | KR20130091321A (enExample) |
| CN (1) | CN103119435A (enExample) |
| AU (1) | AU2011281482B2 (enExample) |
| CA (1) | CA2802402A1 (enExample) |
| ES (1) | ES2609831T3 (enExample) |
| FR (1) | FR2962550B1 (enExample) |
| IL (1) | IL223886B (enExample) |
| MX (1) | MX344783B (enExample) |
| WO (1) | WO2012010765A1 (enExample) |
| ZA (1) | ZA201300099B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104237224A (zh) * | 2014-10-14 | 2014-12-24 | 厦门奥亚仪器有限公司 | 苯二氮卓的快速检测方法及其操作器皿组合 |
| US20220202742A1 (en) * | 2019-05-07 | 2022-06-30 | Clexio Biosciences Ltd. | Dosage forms for preventing drug-facilitated assault |
| US20220175719A1 (en) * | 2020-10-24 | 2022-06-09 | Mason Cave | Dissolvable thc beverage tablet production method |
| US20220241238A1 (en) * | 2020-10-24 | 2022-08-04 | Michael Roth | Method for forming a beverage with a dissolvable thc tablet |
| CN115112582B (zh) * | 2022-05-19 | 2024-08-09 | 西南科技大学 | 一种去甲芬太尼及芬太尼的检测试剂盒及其检测方法 |
| CN117654708A (zh) * | 2023-10-16 | 2024-03-08 | 杭州德望纳米科技有限公司 | 一种基于球磨实验改变蛇纹石粒度分级方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1157662A (en) * | 1966-08-08 | 1969-07-09 | Codex S A | Improvements in or relating to Pharmaceutical Compositions |
| FR2679451B1 (fr) | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
| US6649186B1 (en) * | 1996-09-20 | 2003-11-18 | Ethypharm | Effervescent granules and methods for their preparation |
| FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
| US5948440A (en) * | 1997-12-17 | 1999-09-07 | Ranbaxy Laboratories Limited | Modified release matrix formulation of cefaclor and cephalexin |
| FR2785538B1 (fr) | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Comprime a delitement rapide perfectionne |
| EP1005863A1 (en) * | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
| FR2787715B1 (fr) * | 1998-12-23 | 2002-05-10 | Synthelabo | Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables |
| FR2790387B1 (fr) | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
| WO2001058424A1 (en) * | 2000-02-09 | 2001-08-16 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Floating drug delivery composition |
| US6617123B1 (en) * | 2000-06-29 | 2003-09-09 | Jack V. Smith | Method for detection of 4-hydroxybutyric acid and its precursor(s) in fluids |
| ITMI20011446A1 (it) * | 2001-07-06 | 2003-01-06 | Altergon Sa | Composizioni farmaceutiche di principi attivi suscettibili di somministrazione illecita |
| US20030044989A1 (en) * | 2001-09-04 | 2003-03-06 | Guerra Francisco Javier | Apparatus and method for testing a beverage for a clandestine illicit substance |
| FR2829933B3 (fr) * | 2001-09-21 | 2004-03-12 | Ellipse Pharmaceuticals | Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu |
| FR2829932B1 (fr) * | 2001-09-21 | 2006-11-24 | Ellipse Pharmaceuticals | Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs et produit obtenu |
| FR2831820B1 (fr) | 2001-11-05 | 2004-08-20 | Ethypharm Sa | Comprime orodispersible presentant une grande homogeneite et son procede de preparation |
| US20080102482A1 (en) | 2003-12-19 | 2008-05-01 | Stanley Irwin Grossman | Apparatus for Detecting Drugs in a Beverage |
| WO2008033351A2 (en) * | 2006-09-11 | 2008-03-20 | Theraquest Biosciences, Inc. | Multimodal abuse resistant and extended release formulations |
| JP2009256295A (ja) * | 2008-04-11 | 2009-11-05 | Kosumedei Seiyaku Kk | 化粧用粘着シート |
| JP5059678B2 (ja) * | 2008-04-18 | 2012-10-24 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 着色固形製剤およびその製造方法 |
| FR2962331B1 (fr) * | 2010-07-06 | 2020-04-24 | Ethypharm | Forme pharmaceutique pour lutter contre la soumission chimique, methode la mettant en oeuvre |
-
2010
- 2010-07-06 FR FR1055490A patent/FR2962550B1/fr active Active
-
2011
- 2011-07-05 CN CN2011800334204A patent/CN103119435A/zh active Pending
- 2011-07-05 US US13/808,807 patent/US20130098286A1/en not_active Abandoned
- 2011-07-05 WO PCT/FR2011/051600 patent/WO2012010765A1/fr not_active Ceased
- 2011-07-05 KR KR1020137003073A patent/KR20130091321A/ko not_active Ceased
- 2011-07-05 MX MX2012015103A patent/MX344783B/es active IP Right Grant
- 2011-07-05 JP JP2013517480A patent/JP5916723B2/ja active Active
- 2011-07-05 CA CA2802402A patent/CA2802402A1/fr not_active Abandoned
- 2011-07-05 ES ES11743099.1T patent/ES2609831T3/es active Active
- 2011-07-05 EP EP11743099.1A patent/EP2591350B1/fr active Active
- 2011-07-05 AU AU2011281482A patent/AU2011281482B2/en active Active
- 2011-07-05 KR KR1020187019307A patent/KR101957657B1/ko active Active
-
2012
- 2012-12-25 IL IL223886A patent/IL223886B/en active IP Right Grant
-
2013
- 2013-01-04 ZA ZA2013/00099A patent/ZA201300099B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012010765A1 (fr) | 2012-01-26 |
| KR20130091321A (ko) | 2013-08-16 |
| CN103119435A (zh) | 2013-05-22 |
| AU2011281482A1 (en) | 2013-01-17 |
| KR101957657B1 (ko) | 2019-03-12 |
| US20130098286A1 (en) | 2013-04-25 |
| JP5916723B2 (ja) | 2016-05-11 |
| FR2962550A1 (fr) | 2012-01-13 |
| FR2962550B1 (fr) | 2013-06-14 |
| ES2609831T3 (es) | 2017-04-24 |
| CA2802402A1 (fr) | 2012-01-26 |
| ZA201300099B (en) | 2014-03-26 |
| EP2591350B1 (fr) | 2016-10-26 |
| KR20180080374A (ko) | 2018-07-11 |
| AU2011281482B2 (en) | 2015-10-01 |
| EP2591350A1 (fr) | 2013-05-15 |
| JP2013530206A (ja) | 2013-07-25 |
| IL223886B (en) | 2018-03-29 |
| MX2012015103A (es) | 2013-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX344783B (es) | Metodo y agente para detectar farmacos en bebidas. | |
| ATE474487T1 (de) | Vorrichtung zur herstellung eines aufgebrühten aromatischen getränks | |
| IL204521A0 (en) | Oxadiazole derivatives, their preparation and pharmaceutical compositions containing them | |
| IL200206A (en) | The history of quinaxaline, their preparation and their pharmaceutical preparations | |
| IL219602A0 (en) | Tricylic pyrazol amine derivatives, their preparation and pharmaceutical compositions containing them | |
| WO2009074351A3 (en) | Solid forms of tenofovir disoproxil | |
| WO2011084803A3 (en) | Coloring agents and methods of use thereof | |
| IL195748A0 (en) | Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same | |
| SI2036892T1 (sl) | Derivati tetrahidro h benzazepinov postopek za njihovo pripravo in farmacevtski sestavkiki jih vsebujejo | |
| PT2364983E (pt) | Novo derivado tricíclico ou seus sais farmaceuticamente aceitáveis, seu método de preparação, e composição farmacêutica que o contém | |
| IL191175A (en) | History of H1- and 1-Methyl-4,3-Dihydro-2,5-Dioxo-3-Phylogenes (Pyrid-4-Il-Wild-Phenylmethyl) -H4-–4,1-Benzodiazepine Preparations Pharmacies containing them, and methods for controlling the killing of cells through them | |
| WO2009034177A3 (en) | Diagnostic substances for optical imaging testing on the basis of nanoparticular formulations | |
| BR112012030646A2 (pt) | cartucho de bebida | |
| WO2009031688A3 (en) | Powder composition | |
| IL228265A (en) | History of pyrido {b – 2,3} pyrazine, their preparation and their pharmaceutical preparations | |
| SI1953161T1 (sl) | Novi tricikliäśni derivati, postopek priprave le-teh in farmacevtski sestavki, ki jih vsebujejo | |
| IL280376A (en) | The history of boronic acid, its preparation and pharmaceutical preparations containing it | |
| SI2231598T1 (sl) | Novi derivati diazeniumdiolata postopek pripravele teh in njihovi farmacevtski sestavki | |
| PL2151439T3 (pl) | Pochodna z wprowadzonym atomem azotu i 6-członowym pierścieniem aromatycznym oraz zawierający ją środek farmaceutyczny | |
| WO2006002077A3 (en) | Stable pharmaceutical formulations of benzimidazole compounds | |
| WO2013164426A3 (de) | Lockstoffzusammensetzung | |
| IL199078A (en) | Converted quinoline derivatives, pharmaceutical preparations, combinations and products containing them, their uses and processes for their preparation | |
| IL213588A0 (en) | Naphthyridine derivatives, their preparation and pharmaceutical compositions containing them | |
| ZA200902414B (en) | Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| IL202470A0 (en) | Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |